Article(electronic)#12018
Equity in Sugar-Sweetened Beverage Taxes: Who Pays for Obesity Control?
In: Harvard Public Health Review; Vol 15 (2018)
Search results
Filter
5 results
Sort by:
Checking availability at your location
This article is also available at your library: |
electronic
print
SSRN
Open Access#22020
Autistic Traits Mediate Reductions in Social Attention in Adults with Anorexia Nervosa
The results leading to this publication have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394 for the project AIMS-2-TRIALS. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. Any views expressed are those of the author(s) and not necessarily those of the funders.
BASE
Article(electronic)#3June 9, 2015
Screening and diagnostic assessment of neurodevelopmental disorders in a male prison
In: Journal of intellectual disabilities and offending behaviour: practice, policy and research, Volume 6, Issue 2, p. 102-111
ISSN: 2050-8832
Purpose
– The purpose of this paper is to identify neurodevelopmental disorders and difficulties (NDD) in a male prison. The study used standardised tools to carry out screening and diagnostic assessment of the attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and intellectual disability (ID).
Design/methodology/approach
– The ADHD self-report scale, 20-item autism quotient and the Learning Disability Screening Questionnaire were used to screen 240 male prisoners. Prisoners who screened positive on one or more of these scales or self-reported a diagnosis of ADHD, ASD or ID were further assessed using the diagnostic interview for ADHD in adults, adapted Autism Diagnostic Observation Schedule and the Quick Test.
Findings
– Of the 87 prisoners who screened positive for NDD and were further assessed, 70 met the study's diagnostic criteria for ADHD, ASD or ID. Most of those with NDD (51 per cent) had previously gone unrecognised and a high proportion (51 per cent) were identified through staff- or self-referral to the study.
Originality/value
– The study demonstrated that improving awareness and providing access to skilled, standardised assessment within a male prison can result in increased recognition and identification of NDD.
Checking availability at your location
This article is also available at your library: |
electronic
print
Open Access#42020
Temporal Profiles of Social Attention Are Different Across Development in Autistic and Neurotypical People
The results leading to this publication have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394 for the project AIMS-2-TRIALS. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. Any views expressed are those of the author(s) and not necessarily those of the funders.
BASE
Open Access#52020
Social brain activation during mentalizing in a large autism cohort: the Longitudinal European Autism Project
Moessnang, Carolin; Baumeister, Sarah; Tillmann, Julian; Goyard, David; Charman, Tony; Ambrosino, Sara; Baron-Cohen, Simon; Beckmann, Christian
Moessnang, Carolin; Baumeister, Sarah; Tillmann, Julian; Goyard, David; Charman, Tony; Ambrosino, Sara; Baron-Cohen, Simon; Beckmann, Christian; Bolte, Sven; Bours, Carsten; Crawley, Daisy; Dell'Acqua, Flavio; Durston, Sarah; Ecker, Christine; Frouin, Vincent; Hayward, Hannah; Holt, Rosemary; Johnson, Mark; Jones, Emily; Lai, Meng-Chuan; Lombardo, Michael V; Mason, Luke; Oldenhinkel, Marianne; Persico, Antonio; San Jose Caceres, Antonia; Spooren, Will; Loth, Eva; Murphy, Declan G.M; Buitelaar, Jan K; Banaschewski, Tobias; Brandeis, Daniel; Tost, Heike; Meyer-Lindenberg, Andreas; the EU-AIMS LEAP group
The results leading to this publication have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394 for the project AIMS-2-TRIALS. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. Any views expressed are those of the author(s) and not necessarily those of the funders.
BASE